Serum amyloid A, the major vertebrate acute-phase reactant.

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• The serum amyloid A (SAA) protein family includes acute-phase SAAs (A-SAAs) and constitutive SAAs (C-SAAs).
• A-SAAs are highly conserved across vertebrates and significantly increase during inflammation, while C-SAAs are found only in humans and mice with minimal induction.
• Both SAA types are primarily synthesized in the liver, but extrahepatic production is also observed in mammals.

Purpose of the Study:

• To review the expression, regulation, and proposed functions of the SAA protein family.
• To explore the role of SAAs in host defense and their involvement in chronic inflammatory diseases.

Main Methods:

• Analysis of existing literature on SAA gene and protein expression, regulation, and function.
• Review of studies investigating SAA involvement in inflammation and disease pathogenesis.

Main Results:

• A-SAA mRNA induction is driven by synergistic cytokine signaling (IL-1, IL-6) and enhanced by glucocorticoids.
• Transcription factors like NF-kappaB, C/EBP, and Sp1 regulate A-SAA gene expression.
• SAA proteins are implicated in lipid metabolism, extracellular matrix degradation, and inflammatory cell recruitment.
• SAA is linked to amyloid A amyloidosis, atherosclerosis, and rheumatoid arthritis.

Conclusions:

• SAA proteins play multifaceted roles in inflammation and host defense.
• Further research is needed to fully elucidate the clinical significance of SAAs in various chronic inflammatory conditions.